BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16794004)

  • 1. Biological properties of a novel follicle-stimulating hormone/human chorionic gonadotropin chimeric gonadotropin.
    Garone LM; Ammannati E; Brush TS; Fischer DJ; Tos EG; Luo J; Altobello KL; Ciampolillo C; Ihley TM; Kurosawa E; Tiebout A; McKenna S
    Endocrinology; 2006 Sep; 147(9):4205-12. PubMed ID: 16794004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides.
    LaPolt PS; Nishimori K; Fares FA; Perlas E; Boime I; Hsueh AJ
    Endocrinology; 1992 Dec; 131(6):2514-20. PubMed ID: 1446593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovarian follicle luteinization by recombinant follicle-stimulating hormone.
    Tapanainen JS; Lapolt PS; Perlas E; Hsueh AJ
    Endocrinology; 1993 Dec; 133(6):2875-80. PubMed ID: 8243314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: analysis using chimeric human LH/follicle-stimulating hormone receptors.
    Hirsch B; Kudo M; Naro F; Conti M; Hsueh AJ
    Mol Endocrinol; 1996 Sep; 10(9):1127-37. PubMed ID: 8885247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.
    Fares FA; Suganuma N; Nishimori K; LaPolt PS; Hsueh AJ; Boime I
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4304-8. PubMed ID: 1374895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusing the carboxy-terminal peptide of the chorionic gonadotropin (CG) beta-subunit to the common alpha-subunit: retention of O-linked glycosylation and enhanced in vivo bioactivity of chimeric human CG.
    Furuhashi M; Shikone T; Fares FA; Sugahara T; Hsueh AJ; Boime I
    Mol Endocrinol; 1995 Jan; 9(1):54-63. PubMed ID: 7539107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-evolution of ligand-receptor pairs.
    Moyle WR; Campbell RK; Myers RV; Bernard MP; Han Y; Wang X
    Nature; 1994 Mar; 368(6468):251-5. PubMed ID: 8145825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of human choriogonadotropin into a follitropin by protein engineering.
    Campbell RK; Dean-Emig DM; Moyle WR
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):760-4. PubMed ID: 1899483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor binding and functional properties of chimeric human follitropin prepared by an exchange between a small hydrophilic intercysteine loop of human follitropin and human lutropin.
    Dias JA; Zhang Y; Liu X
    J Biol Chem; 1994 Oct; 269(41):25289-94. PubMed ID: 7929221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone.
    Schubert RL; Narayan P; Puett D
    Endocrinology; 2003 Jan; 144(1):129-37. PubMed ID: 12488338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-induced up- and down-regulation of ovarian follicle-stimulating hormone (FSH) receptor gene expression in immature rats: effects of pregnant mare's serum gonadotropin, human chorionic gonadotropin, and recombinant FSH.
    LaPolt PS; Tilly JL; Aihara T; Nishimori K; Hsueh AJ
    Endocrinology; 1992 Mar; 130(3):1289-95. PubMed ID: 1537292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The groove between the alpha- and beta-subunits of hormones with lutropin (LH) activity appears to contact the LH receptor, and its conformation is changed during hormone binding.
    Cosowsky L; Rao SN; Macdonald GJ; Papkoff H; Campbell RK; Moyle WR
    J Biol Chem; 1995 Aug; 270(34):20011-9. PubMed ID: 7650019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hCG beta residues 94-96 alter LH activity without appearing to make key receptor contacts.
    Han Y; Bernard MP; Moyle WR
    Mol Cell Endocrinol; 1996 Nov; 124(1-2):151-61. PubMed ID: 9027334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic fusion of an alpha-subunit gene to the follicle-stimulating hormone and chorionic gonadotropin-beta subunit genes: production of a bifunctional protein.
    Kanda M; Jablonka-Shariff A; Sato A; Pixley MR; Bos E; Hiro'oka T; Ben-Menahem D; Boime I
    Mol Endocrinol; 1999 Nov; 13(11):1873-81. PubMed ID: 10551781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the immature rat uterotrophic assay for specific measurements of chorionic gonadotropins and follicle-stimulating hormones in vivo bioactivities.
    Lecompte F; Harbeby E; Cahoreau C; Klett D; Combarnous Y
    Theriogenology; 2010 Sep; 74(5):756-64. PubMed ID: 20451992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional hCG analogs adopt different conformations in LH and FSH receptor complexes.
    Wang Y; Bernard MP; Moyle WR
    Mol Cell Endocrinol; 2000 Dec; 170(1-2):67-77. PubMed ID: 11162891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lys91 and His90 of the alpha-subunit are crucial for receptor binding and hormone action of follicle-stimulating hormone (FSH) and play hormone-specific roles in FSH and human chorionic gonadotropin.
    Zeng H; Ji I; Ji TH
    Endocrinology; 1995 Jul; 136(7):2948-53. PubMed ID: 7540545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-chain, triple-domain gonadotropin analogs with disulfide bond mutations in the alpha-subunit elicit dual follitropin and lutropin activities in vivo.
    Jablonka-Shariff A; Kumar TR; Eklund J; Comstock A; Boime I
    Mol Endocrinol; 2006 Jun; 20(6):1437-46. PubMed ID: 16601070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of biologically active fusion genes encoding the common alpha subunit and either the CG beta or FSH beta subunits: role of a linker sequence.
    Sugahara T; Grootenhuis PD; Sato A; Kudo M; Ben-Menahem D; Pixley MR; Hsueh AJ; Boime I
    Mol Cell Endocrinol; 1996 Dec; 125(1-2):71-7. PubMed ID: 9027345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.